 |
alpha1 proteinase inhibitor (human) |
|---|---|
| Trade Name | |
| Orphan Indication | Emphysema secondary to congenital alpha1-antitrypsin deficiency |
| USA Market Approval | USA |
| USA Designation Date | 2010-01-29 00:00:00 |
| Sponsor | Grifols Therapeutics, Inc.;79 TW Alexander Drive;Research Triangle Park, North Carolina, 27709 |
